Literature DB >> 18669882

Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.

Cecilia M Devlin1, Andrew R Leventhal, George Kuriakose, Edward H Schuchman, Kevin Jon Williams, Ira Tabas.   

Abstract

OBJECTIVE: The key initial step in atherogenesis is the subendothelial retention of apolipoprotein B-containing lipoproteins. Acid sphingomyelinase (acid SMase), an enzyme present extracellularly within the arterial wall, strongly enhances lipoprotein retention in model systems in vitro, and retained lipoproteins in human plaques are enriched in ceramide, a product of SMase. We now sought to test a direct causative role for acid SMase in lipoprotein retention and atherogenesis in vivo. METHODS AND
RESULTS: We studied atherogenesis and lipoprotein retention in Asm(-/-) versus Asm(+/+) mice on the Apoe(-/-) and Ldlr(-/-) backgrounds. Asm(-/-);Apoe(-/-) mice had a approximately 40% to 50% decrease in early foam cell aortic root lesion area compared with Asm(+/+);Apoe(-/-) mice (P<0.05) despite no difference in plasma cholesterol or lipoproteins. To assay lipoprotein retention in vivo, the two groups of mice were injected with fluorescently labeled Apoe(-/-) lipoproteins. Early foam cell lesions of Asm(-/-);Apoe(-/-) mice showed a striking 87% reduction in lipoprotein trapping (P<0.0001) compared with Asm(+/+);Apoe(-/-) lesions. Similar results were obtained with Ldlr(-/-) mice, including an 81% reduction in lipoprotein retention within Asm(-/-);Ldlr(-/-) lesions compared with Asm(+/+);Ldlr(-/-) lesions (P<0.0005).
CONCLUSIONS: These findings support a causal role for acid SMase in lipoprotein retention and lesion progression and provides further support for the response-to-retention model of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669882      PMCID: PMC2562252          DOI: 10.1161/ATVBAHA.108.173344

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

1.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.

Authors:  D C Schwenke; T E Carew
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

Review 2.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

3.  Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux.

Authors:  A R Leventhal; W Chen; A R Tall; I Tabas
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

4.  Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.

Authors:  S L Schissel; X Jiang; J Tweedie-Hardman; T Jeong; E H Camejo; J Najib; J H Rapp; K J Williams; I Tabas
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

5.  Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

Authors:  S L Schissel; J Tweedie-Hardman; J H Rapp; G Graham; K J Williams; I Tabas
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

7.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.

Authors:  R L Reddick; S H Zhang; N Maeda
Journal:  Arterioscler Thromb       Date:  1994-01

8.  Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.

Authors:  I Tabas; Y Li; R W Brocia; S W Xu; T L Swenson; K J Williams
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.

Authors:  K Horinouchi; S Erlich; D P Perl; K Ferlinz; C L Bisgaier; K Sandhoff; R J Desnick; C L Stewart; E H Schuchman
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

10.  Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media.

Authors:  B G Nordestgaard; R Wootton; B Lewis
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

View more
  56 in total

1.  nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice.

Authors:  Tom Lallemand; Myriam Rouahi; Audrey Swiader; Marie-Hélène Grazide; Nancy Geoffre; Paul Alayrac; Emeline Recazens; Agnès Coste; Robert Salvayre; Anne Nègre-Salvayre; Nathalie Augé
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-24       Impact factor: 8.311

2.  Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.

Authors:  Abigail S Haka; Inna Grosheva; Ethan Chiang; Adina R Buxbaum; Barbara A Baird; Lynda M Pierini; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

Review 3.  Cholesterol, the central lipid of mammalian cells.

Authors:  Frederick R Maxfield; Gerrit van Meer
Journal:  Curr Opin Cell Biol       Date:  2010-06-02       Impact factor: 8.382

Review 4.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

5.  Dynamic Actin Reorganization and Vav/Cdc42-Dependent Actin Polymerization Promote Macrophage Aggregated LDL (Low-Density Lipoprotein) Uptake and Catabolism.

Authors:  Rajesh K Singh; Abigail S Haka; Priya Bhardwaj; Xiaohui Zha; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

Review 6.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

7.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

8.  Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis.

Authors:  Xiang Li; Ming Xu; Ashley L Pitzer; Min Xia; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  J Mol Med (Berl)       Date:  2014-01-25       Impact factor: 4.599

Review 9.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

10.  Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.

Authors:  Abigail S Haka; Inna Grosheva; Rajesh K Singh; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.